Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$19.8M
+1.9% from 2023
Prescriptions
2,683
$7,362.42 per claim
Patients
473
507 prescribers
Total spending, 2024
$19.8M
$41,761.90 per patient
Medicare prescription drug plans paid $19.8M for Thalomid in 2024, for 2,683 prescriptions and refills to 473 patients (up 1.9% from 2023). The average cost per claim was $7,362.42.
New York had the highest Medicare cost for Thalomid in 2024: $2.1M for 275 claims, followed by North Carolina ($1.6M).
Hector R Leon-Figueroa, internal medicine in Rio Piedras, PR, had the highest Medicare cost for Thalomid in 2024: 30 claims costing $412K.
Thalomid is made by Bristol-Myers Squibb Company (BMY), listed in the Medicare spending data as Celgene/BMS.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Hector R Leon-Figueroa Rio Piedras, PR | Internal Medicine | 30 | Under 11 | $412K |
| Joseph L Jorizzo Winston Salem, NC | Dermatology | 67 | 15 | $388K |
| Andrew L Himelstein |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 583 | 3,390 | 607 | $24.5M |
| 2023 | 502 | 2,707 | 499 | $19.4M |
| 2024 | 507 | 2,683 | 473 | $19.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 25 |
| Under 11 |
| $365K |
| Jorge M Abdallah Greenville, NC | Hematology-Oncology | 33 | Under 11 | $363K |
| Fengshuo Lan Stony Brook, NY | Medical Oncology | 14 | Under 11 | $249K |
| Dejuania A Brown-Rawls Myrtle Beach, SC | Hematology-Oncology | 14 | Under 11 | $222K |
| Gershwin T Blyden Miami, FL | Internal Medicine | 26 | Under 11 | $198K |
| Gerald A Colvin Wakefield, RI | Hematology-Oncology | 12 | Under 11 | $188K |
| Peter F Cronholm Philadelphia, PA | Family Practice | 13 | Under 11 | $186K |
| Robert V Emmons Louisville, KY | Hematology-Oncology | 13 | Under 11 | $178K |
| Morey A Blinder Saint Louis, MO | Hematology | 13 | Under 11 | $175K |
| Michael H Veeder Peoria, IL | Hematology-Oncology | 12 | Under 11 | $163K |
| Chien-Huan Chen Saint Louis, MO | Gastroenterology | 16 | Under 11 | $152K |
| Andrea D Maderal Miami, FL | Dermatology | 25 | Under 11 | $151K |
| James N Butera Providence, RI | Hematology-Oncology | 27 | Under 11 | $151K |
| Amy B Awaida Youngstown, OH | Hematology-Oncology | 12 | Under 11 | $148K |
| Brian J Leberthon West Covina, CA | Hematology-Oncology | 11 | Under 11 | $143K |
| Paul M Brager Bridgport, WV | Hematology-Oncology | 18 | Under 11 | $142K |
| Hayley S Bierman Little Rock, AR | Nurse Practitioner | 24 | 12 | $140K |
| Hyun Joo Kim Minneapolis, MN | Pulmonary Disease | 22 | Under 11 | $140K |
| Gregory P Monohan Lexington, KY | Hematology-Oncology | 13 | Under 11 | $137K |
| Lori E Fantry Tucson, AZ | Infectious Disease | 20 | Under 11 | $127K |
| David M Paul Phoenix, AZ | Hematology-Oncology | 24 | Under 11 | $122K |
| Daniel F Mitchell Thomasville, GA | Dermatology | 14 | Under 11 | $120K |
| Sreenivas V Rao Florence, SC | Hematology-Oncology | 15 | Under 11 | $120K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Celgene/BMS BMY | 2,683 | $19.8M |